Genolution Statistics
Total Valuation
Genolution has a market cap or net worth of KRW 45.98 billion. The enterprise value is 39.48 billion.
Market Cap | 45.98B |
Enterprise Value | 39.48B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Genolution has 18.07 million shares outstanding. The number of shares has decreased by -1.26% in one year.
Current Share Class | 18.07M |
Shares Outstanding | 18.07M |
Shares Change (YoY) | -1.26% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | 13.81% |
Owned by Institutions (%) | 0.02% |
Float | 12.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.24 |
PB Ratio | 0.62 |
P/TBV Ratio | 0.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.85 |
EV / Sales | 4.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.66 |
Financial Position
The company has a current ratio of 5.90, with a Debt / Equity ratio of 0.32.
Current Ratio | 5.90 |
Quick Ratio | 5.26 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | -2.24 |
Interest Coverage | -10.25 |
Financial Efficiency
Return on equity (ROE) is -13.54% and return on invested capital (ROIC) is -5.24%.
Return on Equity (ROE) | -13.54% |
Return on Assets (ROA) | -5.12% |
Return on Invested Capital (ROIC) | -5.24% |
Return on Capital Employed (ROCE) | -9.24% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.08 |
Inventory Turnover | 2.05 |
Taxes
Income Tax | -564.23M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.90% in the last 52 weeks. The beta is -0.01, so Genolution's price volatility has been lower than the market average.
Beta (5Y) | -0.01 |
52-Week Price Change | -28.90% |
50-Day Moving Average | 2,276.40 |
200-Day Moving Average | 2,391.03 |
Relative Strength Index (RSI) | 62.60 |
Average Volume (20 Days) | 1,160,148 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genolution had revenue of KRW 8.77 billion and -10.26 billion in losses. Loss per share was -567.52.
Revenue | 8.77B |
Gross Profit | 3.85B |
Operating Income | -8.76B |
Pretax Income | -11.43B |
Net Income | -10.26B |
EBITDA | -6.39B |
EBIT | -8.76B |
Loss Per Share | -567.52 |
Balance Sheet
The company has 30.69 billion in cash and 24.15 billion in debt, giving a net cash position of 6.53 billion or 361.58 per share.
Cash & Cash Equivalents | 30.69B |
Total Debt | 24.15B |
Net Cash | 6.53B |
Net Cash Per Share | 361.58 |
Equity (Book Value) | 74.65B |
Book Value Per Share | 4,140.82 |
Working Capital | 29.92B |
Cash Flow
In the last 12 months, operating cash flow was -6.75 billion and capital expenditures -4.04 billion, giving a free cash flow of -10.78 billion.
Operating Cash Flow | -6.75B |
Capital Expenditures | -4.04B |
Free Cash Flow | -10.78B |
FCF Per Share | -596.93 |
Margins
Gross margin is 43.94%, with operating and profit margins of -99.87% and -116.99%.
Gross Margin | 43.94% |
Operating Margin | -99.87% |
Pretax Margin | -130.34% |
Profit Margin | -116.99% |
EBITDA Margin | -72.87% |
EBIT Margin | -99.87% |
FCF Margin | n/a |
Dividends & Yields
Genolution does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.26% |
Shareholder Yield | n/a |
Earnings Yield | -22.31% |
FCF Yield | -23.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.
Last Split Date | Apr 19, 2023 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Genolution has an Altman Z-Score of 2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2 |
Piotroski F-Score | 3 |